Viking Global Equities Master Ltd., 10% Owner at Urovant Sciences Ltd. (UROV), bought 17,746 shares at $7.97 ($139K) on 2019-05-30, disclosed to the SEC on 2019-06-03.
Scheduled purchase ($139k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.97 | 6,951 | $55K | 39.9% |
| 2 | $8.91 | 300 | $3K | 1.9% |
| 3 | $7.70 | 5,071 | $39K | 28.1% |
| 4 | $7.71 | 5,424 | $42K | 30.1% |
| Total | $7.83 avg | 17,746 | $139K | 100% |